Managing Choroidal Metastasis in Cancer Patients
Author Information
Author(s): Evbuomwan Moses O., Bhuyan Rupak, Uzomah Uwajachukwumma A., Jamshidi Farzad, Anderson Carryn, Boldt H. Culver, Binkley Elaine
Primary Institution: University of Iowa
Hypothesis
What is the optimal management strategy for patients with choroidal metastatic tumors in the era of targeted cancer therapy?
Conclusion
Patients with choroidal/ciliary body metastasis treated with either external beam radiation or systemic therapy can have good visual outcomes.
Supporting Evidence
- Choroidal metastases are the most common intraocular malignancies in adults.
- External beam radiation has been the standard treatment but newer therapies show promise.
- The average time from diagnosis of ocular metastasis to death was 8 months.
Takeaway
This study looked at how to treat eye tumors that come from other cancers. Both radiation and medicine can help people see better.
Methodology
A retrospective review of patients with choroidal/ciliary body metastases managed over a five-year period.
Potential Biases
Selection of systemic therapy was based on systemic tumors rather than ocular metastases.
Limitations
The sample size is relatively small, and the study is retrospective.
Participant Demographics
Mean age was 59 years, with equal gender distribution and all participants being Caucasian.
Statistical Information
P-Value
0.48
Statistical Significance
p=0.48
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website